CDX2 and non-small cell lung carcinoma: In contrast to these results, another study in 194 Caucasian patients (from Spain) diagnosed with NSCLC associated the VDR rs11568820 (Cdx2)-TT genotype with lower overall survival in the patients (p = 0.013, HR = 7.43, 95% CI =1.53–36.15; TT vs. CC/CT) [25].